Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED) stands against the other high growth healthcare stocks. During lean economic times, investing in healthcare ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company ...

In trading on Friday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of 23.1, after changing hands as low as $54.75 per share. By comparison ...

but between legacy GMED, and NuVasive looking ahead and I had a follow-up. And with no further questions that concludes the Globus Medical Earnings Call. Thank you for participating. You may now ...

GLOBUS MEDICAL ($GMED) posted quarterly earnings results on Thursday, February 20th. The company reported earnings of $0.84 per share, beating estimates of $0.76 by ...

Welcome to Globus Medical's second quarter 2023 earnings call. [Operator instructions] I will now turn the call over to Brian Kearns, senior vice president of business development and investor ...